Literature DB >> 9343252

A second form of infectious bursal disease virus-associated tubule contains VP4.

H Granzow1, C Birghan, T C Mettenleiter, J Beyer, B Köllner, E Mundt.   

Abstract

Preparations of density gradient-purified infectious bursal disease virus (IBDV) were found to contain full and empty icosahedral virions, type I tubules with a diameter of about 60 nm, and type II tubules 24 to 26 nm in diameter. By immunoelectron microscopy we demonstrate that virions and both types of tubular structures specifically react with anti-IBDV serum. In infected cells intracytoplasmic and intranuclear type II tubules reacted exclusively with an anti-VP4 monoclonal antibody, as did type II tubules in virion preparations. The immunofluorescence pattern with the anti-VP4 antibody correlated with electron microscopical findings. Neither purified extracellular nor intracellular virions were labeled with the anti-VP4 MAb. Our data show that the type II tubules contain VP4 and suggest that VP4 is not part of the virus particle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343252      PMCID: PMC192358     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Characterization of the tubules associated with the replication of three different orbiviruses.

Authors:  H Huismans; H J Els
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  VP5 of infectious bursal disease virus is not essential for viral replication in cell culture.

Authors:  E Mundt; B Köllner; D Kretzschmar
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies.

Authors:  F A Murphy; E C Borden; R E Shope; A Harrison
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Immuno-electron microscopic study on the antigenicity of tubular structures associated with human rotavirus.

Authors:  T Kimura
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

Review 6.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

7.  Morphogenesis and fine structure of eel virus (Berlin), a member of the proposed Birnavirus group.

Authors:  I Schwanz-Pfitzner; M Ozel; G Darai; H Gelderblom
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Fine-structure studies of the avian infectious bursal agent. I. In vivo viral morphogenesis.

Authors:  P D Lunger; T C Maddux
Journal:  Avian Dis       Date:  1972 Jul-Sep       Impact factor: 1.577

9.  Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles.

Authors:  H Müller; H Becht
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

10.  Synthetic transcripts of double-stranded Birnavirus genome are infectious.

Authors:  E Mundt; V N Vakharia
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more
  15 in total

1.  The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2.

Authors:  Bruno Da Costa; Christophe Chevalier; Celine Henry; Jean-Claude Huet; Stéphanie Petit; Jean Lepault; Hein Boot; Bernard Delmas
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress.

Authors:  Sophie Turcotte; Josée Letellier; Roger Lippé
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication.

Authors:  Ruth L O Stricker; Sven-Erik Behrens; Egbert Mundt
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids.

Authors:  Christophe Chevalier; Jean Lepault; Inge Erk; Bruno Da Costa; Bernard Delmas
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Authors:  J R Castón; J L Martínez-Torrecuadrada; A Maraver; E Lombardo; J F Rodríguez; J I Casal; J L Carrascosa
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Critical roles of glucocorticoid-induced leucine zipper in infectious bursal disease virus (IBDV)-induced suppression of type I Interferon expression and enhancement of IBDV growth in host cells via interaction with VP4.

Authors:  Zhonghua Li; Yongqiang Wang; Xiang Li; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

7.  Early, active, and specific localization of herpes simplex virus type 1 gM to nuclear membranes.

Authors:  Jie Zhang; Claus-Henning Nagel; Beate Sodeik; Roger Lippé
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

8.  The last C-terminal residue of VP3, glutamic acid 257, controls capsid assembly of infectious bursal disease virus.

Authors:  Christophe Chevalier; Jean Lepault; Bruno Da Costa; Bernard Delmas
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Crystal structures of yellowtail ascites virus VP4 protease: trapping an internal cleavage site trans acyl-enzyme complex in a native Ser/Lys dyad active site.

Authors:  Ivy Yeuk Wah Chung; Mark Paetzel
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

10.  Formation of virus-like particles when the polyprotein gene (segment A) of infectious bursal disease virus is expressed in insect cells.

Authors:  F S Kibenge; B Qian; E Nagy; J R Cleghorn; D Wadowska
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.